ClinicalTrials.gov record
Completed Phase 3 Interventional

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

ClinicalTrials.gov ID: NCT05980260

Public ClinicalTrials.gov record NCT05980260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 3:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05980260
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
HELP for NOWS Consortium
Network
Enrollment
626 participants

Conditions and interventions

Interventions

  • Scheduled Opioid Taper Approach Other
  • Symptom-based Dosing Approach Other

Other

Eligibility (public fields only)

Age range
1 Hour to 48 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2024
Primary completion
May 26, 2025
Completion
Jul 14, 2025
Last update posted
May 17, 2026

2024 – 2025

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
ChristianaCare Wilmington Delaware 19801
University of South Florida Health Tampa Florida 33606
Sidney & Lois Eskenazi Hospital Indianapolis Indiana 46202
University of Louisville Hospital Jeffersonville Indiana 47130
University of Kansas Hospital Kansas City Kansas 66160
St. Elizabeth Healthcare Edgewood Kentucky 41017
Kentucky Children's Hospital Lexington Kentucky 40536
Norton Children's Hospital Louisville Kentucky 40202
Norton Women's and Children's Hospital Louisville Kentucky 40207
University of Nebraska Medical Center Omaha Nebraska 68198
AtlantiCare Regional Medical Center Atlantic City New Jersey 08401
University of New Mexico Health Sciences Center Albuquerque New Mexico 87131
University of Rochester Medical Center Rochester New York 14642
Good Samaritan Hospital Cincinnati Ohio 45202
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Kettering Health Main Campus Kettering Ohio 45429
Oklahoma Children's Hospital OU Health Oklahoma City Oklahoma 73104
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Pennsylvania Hospital Philadelphia Pennsylvania 19107
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
University of Utah Health Salt Lake City Utah 84158

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05980260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05980260 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →